One common fusion partner in lung adenocarcinoma is KIF5B. The RET-KIF5B fusion retains a kinase domain from RET and a coiled-coil domain from KIF5B, which induces homodimerization and activates the oncogenic TK domain by autophosphorylation [50, 51]. This evidence concerns the gene KIF5B and lung adenocarcinoma.